These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 2877025

  • 1. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF, Vlasova EV, Dmitrieva LN, Trapezov EV, Gorbacheva LD.
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [Abstract] [Full Text] [Related]

  • 2. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF, Sergeeva TI, Panteleev EI, Vlasova EV, Dmitrieva LN.
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [Abstract] [Full Text] [Related]

  • 3. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
    Petrov RV, Shemanova GF, Kaverzneva ED, Kissel' VL, Panteleev EI.
    Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
    [Abstract] [Full Text] [Related]

  • 4. The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A.
    Shemanova GF, Vlasova EV, Sergeeva TI, Panteleyev EI.
    Arch Roum Pathol Exp Microbiol; 1981 Dec; 40(4):299-303. PubMed ID: 6280638
    [No Abstract] [Full Text] [Related]

  • 5. [Immunogenic properties of Clostridium perfringens type A anatheta-hemolysin].
    Sergeeva TI, Dolgikh MS, Blagoveshchenskiĭ VA.
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):71-5. PubMed ID: 6275640
    [Abstract] [Full Text] [Related]

  • 6. [Preparation and evaluation of immunogenic properties of Clostridium perfringens type A toxoid].
    Rymkiewicz D, Sawicki J, Brühl A, Sochańska R.
    Med Dosw Mikrobiol; 1979 Nov; 31(2):95-102. PubMed ID: 228130
    [No Abstract] [Full Text] [Related]

  • 7. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK, Siber GR.
    Dev Biol Stand; 1996 Nov; 86():207-15. PubMed ID: 8785950
    [Abstract] [Full Text] [Related]

  • 8. On the in vitro neutralization test of Clostridium perfringens type A toxin.
    Shemanova GF, Vlasova EV, Postnikova TM.
    J Hyg Epidemiol Microbiol Immunol; 1988 Nov; 32(2):219-26. PubMed ID: 2900852
    [Abstract] [Full Text] [Related]

  • 9. [Homogeneous Cl. perfringens alpha-anatoxin: its physicochemical and immunogenic properties].
    Shemanova GF, Petrov RV, Dmitrieva LN, Panteleev EI, Drachev VA.
    Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):117-22. PubMed ID: 208330
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity of highly purified -toxoid of Clostridium perfringens.
    Sato H, Kameyama S, Murata R.
    Jpn J Med Sci Biol; 1972 Feb; 25(1):53-6. PubMed ID: 4338981
    [No Abstract] [Full Text] [Related]

  • 11. [Characteristics of the immunologic response of animals to Clostridium perfringens anatoxin].
    Petrov RV, Shemanova GF, Panteleev EI, Dmitrieva LN, Vlasova EV.
    Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):71-4. PubMed ID: 197752
    [Abstract] [Full Text] [Related]

  • 12. Development, preparation and safety testing of a Clostridium welchii type C toxoid. I: preliminary observations in man in Papua New Guinea.
    Walker PD, Foster WH, Knight PA, Freestone DS, Lawrence G.
    J Biol Stand; 1979 May; 7(4):315-23. PubMed ID: 231605
    [Abstract] [Full Text] [Related]

  • 13. Antitoxin response in cattle vaccinated with Clostridium perfringens type C toxoid.
    Kennedy KK, Norris SJ, Beckenhauer WH, White RG.
    Vet Med Small Anim Clin; 1977 Jul; 72(7):1213-5. PubMed ID: 196381
    [No Abstract] [Full Text] [Related]

  • 14. The standardization of Cl. perfringens antigens and antisera.
    Jansen BC.
    Dev Biol Stand; 1976 Jul; 32():35-44. PubMed ID: 187510
    [Abstract] [Full Text] [Related]

  • 15. Antitoxin titer in colostrum and milk after vaccination of sows with Clostridium perfringens type C toxoid vaccine.
    Djurickovic SM, Dworak JE, Wickham KL.
    Vet Med Small Anim Clin; 1975 Mar; 70(3):283-5. PubMed ID: 164076
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.